During the last session, Biodesix Inc (NASDAQ:BDSX)’s traded shares were 4.16 million, with the beta value of the company hitting 1.14. At the end of the trading day, the stock’s price was $1.22, reflecting an intraday gain of 2.49% or $0.03. The 52-week high for the BDSX share is $2.21, that puts it down -81.15 from that peak though still a striking 9.02% gain since the share price plummeted to a 52-week low of $1.11. The company’s market capitalization is $177.42M, and the average intraday trading volume over the past 10 days was 0.63 million shares, and the average trade volume was 283.74K shares over the past three months.
Biodesix Inc (BDSX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BDSX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.07.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biodesix Inc (NASDAQ:BDSX) trade information
Biodesix Inc (BDSX) registered a 2.49% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.49% in intraday trading to $1.22, hitting a weekly high. The stock’s 5-day price performance is -12.89%, and it has moved by -22.81% in 30 days. Based on these gigs, the overall price performance for the year is -7.61%. The short interest in Biodesix Inc (NASDAQ:BDSX) is 0.42 million shares and it means that shorts have 2.72 day(s) to cover.
The consensus price target of analysts on Wall Street is $3, which implies an increase of 59.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $3 respectively. As a result, BDSX is trading at a discount of -145.9% off the target high and -145.9% off the low.
Biodesix Inc (BDSX) estimates and forecasts
Statistics show that Biodesix Inc has outperformed its competitors in share price, compared to the industry in which it operates. Biodesix Inc (BDSX) shares have gone down -13.50% during the last six months, with a year-to-date growth rate more than the industry average at 43.55% against 4.70. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 31.67% this quarter and then jump 50.00% in the quarter after that. In the rating firms’ projections, revenue will increase 44.09% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 19.83M as predicted by 6 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 20.22M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 14.67M and 14.82M respectively. In this case, analysts expect current quarter sales to grow by 35.21% and then jump by 36.46% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 8.42%. While earnings are projected to return 45.63% in 2024.
BDSX Dividends
Biodesix Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Biodesix Inc (NASDAQ:BDSX)’s Major holders
Biodesix Inc insiders own 47.12% of total outstanding shares while institutional holders control 38.64%, with the float percentage being 73.07%. TELEMARK ASSET MANAGEMENT, LLC is the largest shareholder of the company, while 58.0 institutions own stock in it. As of 2024-06-30, the company held over 8.28 million shares (or 8.5241% of all shares), a total value of $12.67 million in shares.
The next largest institutional holding, with 6.11 million shares, is of SOLEUS CAPITAL MANAGEMENT, L.P.’s that is approximately 6.2902% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $9.35 million.
Also, the Mutual Funds coming in first place with the largest holdings of Biodesix Inc (BDSX) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 1.44 shares. This amounts to just over 0.99 percent of the company’s overall shares, with a $1.77 million market value. The same data shows that the other fund manager holds slightly less at 1.42, or about 0.98% of the stock, which is worth about $1.75 million.
